logo-loader
viewBoundless Bio

Boundless Bio takes big steps forward filling out their staff

Boundless Bio CEO Zachary Hornby sat down with Proactive’s Christine Corrado at BIO CEO in New York. is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA  to deliver transformative therapies to patients with previously intractable cancers.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 opens in red ahead of US job numbers; Bail-out for...

Headlines from the Proactive UK newsroom. London’s leading shares are set to open on the back foot this morning ahead of the release later of US jobs figures for March.. But economists say the full scale of the rising jobless in the US economy will be revealed in next month’s...

19 hours, 39 minutes ago

2 min read